Celanese (CE)

NYSE Materials Specialty Chemicals S&P SmallCap 600
$46.49
-1.35 (-2.82%)
Close of Nov 06, 2026 · end-of-day data
Source: Celanese's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$5.39B$6.14B$7.16B$6.30B$5.66B$8.54B$9.67B$10.93B$10.27B$9.54B
Cost of revenue$3.98B$4.63B$5.18B$4.69B$4.36B$5.86B$7.29B$8.34B$7.93B$7.59B
Gross profit$1.41B$1.51B$1.97B$1.61B$1.29B$2.68B$2.38B$2.58B$2.34B$1.95B
Research & development$78.00M$73.00M$72.00M$67.00M$74.00M$86.00M$112.00M$146.00M$130.00M$125.00M
Selling, general & admin$378.00M$496.00M$546.00M$483.00M$482.00M$633.00M$824.00M$1.08B$1.03B$899.00M
Operating income$934.00M$857.00M$1.33B$834.00M$664.00M$1.95B$1.38B$1.67B-$720.00M-$786.00M
Interest expense$120.00M$122.00M$125.00M$115.00M$109.00M$91.00M$405.00M$720.00M$676.00M$701.00M
Pre-tax income$1.03B$1.07B$1.51B$988.00M$2.25B$2.25B$1.42B$1.16B-$1.02B-$1.22B
Income tax$122.00M$213.00M$292.00M$124.00M$247.00M$330.00M-$489.00M-$795.00M$507.00M-$90.00M
Net income$900.00M$843.00M$1.21B$852.00M$1.99B$1.89B$1.89B$1.94B-$1.54B-$1.17B
EBITDA$1.22B$1.16B$1.68B$1.19B$1.01B$2.32B$1.84B$2.37B$81.00M-$26.00M
EPS (basic)$6.21$6.11$8.99$6.88$16.85$16.99$17.48$17.85$-14.11$-10.64
EPS (diluted)$6.18$6.09$8.91$6.84$16.75$16.86$17.34$17.76$-14.11$-10.64
Diluted shares145.67M138.32M135.42M124.65M118.48M112.08M109.24M109.38M109.27M109.53M
Gross margin26.1%24.6%27.6%25.5%22.9%31.4%24.6%23.6%22.8%20.5%
Operating margin17.3%14.0%18.6%13.2%11.7%22.8%14.2%15.2%-7.0%-8.2%
Net margin16.7%13.7%16.9%13.5%35.1%22.1%19.6%17.8%-15.0%-12.2%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$638.00M$576.00M$439.00M$463.00M$955.00M$536.00M$1.51B$1.80B$962.00M$1.26B
Short-term investments$30.00M$32.00M$31.00M$40.00M$533.00M$10.00M————
Receivables$801.00M$986.00M$1.02B$850.00M$792.00M$1.16B$1.38B$1.24B$1.12B$922.00M
Inventory$720.00M$900.00M$1.05B$1.04B$978.00M$1.52B$2.81B$2.36B$2.28B$2.22B
Total current assets$2.47B$2.79B$2.87B$2.77B$3.76B$3.81B$6.61B$6.22B$5.13B$5.69B
Goodwill$796.00M$1.00B$1.06B$1.07B$1.17B$1.41B$7.14B$6.98B$5.39B$4.17B
Total assets$8.36B$9.54B$9.31B$9.48B$10.91B$11.97B$26.27B$26.60B$22.84B$21.70B
Total current liabilities$1.08B$1.56B$1.78B$1.75B$1.97B$2.50B$4.07B$4.07B$3.89B$3.68B
Short-term debt$118.00M$326.00M$561.00M$496.00M$496.00M$791.00M$1.31B$1.38B$1.50B$1.20B
Long-term debt$2.89B$3.31B$2.97B$3.41B$3.23B$3.18B$13.37B$13.40B$12.53B$12.61B
Total debt$3.01B$3.64B$3.53B$3.90B$3.72B$3.97B$14.68B$14.78B$14.03B$13.82B
Total liabilities$5.77B$6.65B$6.33B$6.97B$7.38B$7.79B$20.64B$19.53B$17.71B$17.65B
Shareholders' equity$2.59B$2.89B$2.98B$2.51B$3.53B$4.19B$5.64B$7.07B$5.13B$4.05B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$893.00M$803.00M$1.56B$1.45B$1.34B$1.76B$1.82B$1.90B$966.00M$1.15B
Capital expenditures$246.00M$267.00M$337.00M$370.00M$364.00M$467.00M$543.00M$568.00M$435.00M$343.00M
Free cash flow$647.00M$536.00M$1.22B$1.08B$979.00M$1.29B$1.28B$1.33B$531.00M$803.00M
Investing cash flow-$439.00M-$549.00M-$507.00M-$493.00M$592.00M-$1.12B-$11.14B-$134.00M-$470.00M-$349.00M
Financing cash flow-$759.00M-$351.00M-$1.17B-$935.00M-$1.47B-$1.04B$10.29B-$1.46B-$1.31B-$513.00M
Dividends paid$201.00M$241.00M$280.00M$300.00M$293.00M$304.00M$297.00M$305.00M$307.00M$13.00M
Share buybacks$500.00M$500.00M$805.00M$996.00M$650.00M$1.00B$17.00M$0$0—
Stock-based compensation$31.00M$47.00M$71.00M$48.00M$28.00M$95.00M$60.00M$40.00M$32.00M$24.00M
Depreciation & amortization$290.00M$305.00M$343.00M$352.00M$350.00M$371.00M$462.00M$706.00M$801.00M$760.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.